Please login to the form below

2insights Research

We have a strong focus and specialization in the Medical/Healthcare field, especially for very niche targets (both patients and physicians) and moderators with specific expertise. We provide market research services in the UK, Europe, MENA and Asian Countries.

This is a FREE listing




Below are full profiles from other companies in this area

Origins Insights

Origins are part of the Resonant Group. Using novel research methodologies, we dig deeper to deliver authentic audience experiences that transform your thinking and redefine success. Our research methodologies give our clients a 360° view of patients’ everyday lives, putting them in the driving seat to improve outcomes. Immersive. Emotive. Transformative.

View profile

IPG Health Medical Communications

We are the world's most celebrated and awarded Medical Communications agencies. We are 800 experts obsessed with combining science, creativity and technology to exceptional medical communications solutions for our clients.

View profile

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View profile

Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.

View profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and its complexities, Onyx Health helps clients grow their brands and build their reputation to increase their sales.

View profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View profile

Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural science. Frontera's range of products and methodologies help clients to improve outcomes and transform lives.

View profile

Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to ensure patients gain access to life changing medicines and devices. A vision to make a positive impact on the success of our clients, the economy and the wider society.

View profile

Research Partnership

Research Partnership is now a member of Inizio Advisory, the consulting business unit of Inizio, a strategic partner for health and life sciences with a full suite of medical, marketing, advisory and engage services. As the market insights specialist of this curated group of companies, we collaborate with clients from the global pharmaceutical, medtech and biotech industries, providing research intelligence and strategic recommendations that elevate healthcare brands and power their success.

View profile

Company Details

2insights Research

Telephone:01422 343255

Contact

Address:
34 Savile Drive
Halifax
West Yorkshire
HX1 2EU
United Kingdom

Latest content from PMHub

Live Webinar: Patient Centric Approaches for Rare and Ultra-Rare Diseases
A Fireside Chat with Lawrence Bressler, Head of Value & Market Access, Global Rare Diseases at Chiesi Impetus Digital
Overcoming Patient Recruitment Challenges in Rare Disease Trials
Rare diseases are thought to affect up to 446 million people worldwide. With more than 7,000 rare diseases, most of which are genetic, it’s vital all patients can access new and effective treatments.We know patient recruitment can be challenging even for non-complex trials, but this issue is exacerbated for rare disease studies due to the much smaller patient populations involved. This can lead to lengthy delays in bringing what can be cutting-edge and potentially life-changing therapies to market.With the global rare disease market expected to be worth more than US$547 billion within the next 10 years overcoming these challenges is critical. This webinar will:explore some of the patient recruitment challenges in rare disease studies, particularly relating to sickle cell trialshear from a patient and family member about what it means to live with a rare disease and highlight strategies to accelerate patient recruitment for these specialized trials.Learning ObjectivePatient recruitment challenges in rare disease studiesChallenges in sickle cells studiesFamily/Patient perspectiveAccelerating patient recruitment in rare disease studiesSpeaker 1 - Whitney Taynton - Business Unit Head, Site Enrollment Optimization, Innovative TrialsSpeaker 2 - Donna Dail - Director, Patient Recruitment Programs (Rare Disease)Speaker 3 - Margaret Alege - Patient Innovative Trials
Medscape presents Digital Health in Practice: Impact & Insights at Reuters #Pharma2020
Medscape Education Global
Modern Medical Affairs: How to Leverage Tech and Data as an MSL
Dr. Luca Dezzani, VP of US Oncology Medical Affairs at Johnson & Johnson, explores innovation in Medical Affairs, new technologies for data dissemination and medical education, how to engage with different healthcare stakeholders, plus much more. Impetus Digital